Abaloparatide For Risk Reduction of Nonvertebral And Vertebral Fractures In Postmenopausal Women With Osteoporosis: A Network Meta-Analysis

To assess the relative efficacy of abaloparatide compared with osteoporosis treatment options (alendronate, denosumab, ibandronate, raloxifene, risedronate, romosozumab, strontium ranelate, teriparatide, zoledronic acid).

Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: J Reginster, F Bianic, R Campbell, M Martin, S Williams, L Fitzpatrick Source Type: research